| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
-Inducible Protein-10) Control of Encephalitogenic CD4+ T Cell Accumulation in the Central Nervous System During Experimental Autoimmune Encephalomyelitis1
*
Department of Pathology, Immunobiology Center, Robert H. Lurie Cancer Center, and Institute for Neuroscience, Northwestern University Medical School, Chicago, IL 60611;
Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109; and
Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Charlestown, MA 02129
Experimental autoimmune encephalomyelitis (EAE) is a
CD4+ Th1-mediated demyelinating disease of the CNS that
serves as a model for multiple sclerosis. A critical event in the
pathogenesis of EAE is the entry of both Ag-specific and Ag-nonspecific
T lymphocytes into the CNS. In the present report, we investigated the
role of the CXC chemokine CXCL10 (IFN-
-inducible protein-10) in the
pathogenesis of EAE. Production of CXCL10 in the CNS correlated with
the development of clinical disease. Administration of anti-CXCL10
decreased clinical and histological disease incidence, severity, as
well as infiltration of mononuclear cells into the CNS. Anti-CXCL10
specifically decreased the accumulation of encephalitogenic
PLP139–151 Ag-specific CD4+ T cells in the CNS
compared with control-treated animals. Anti-CXCL10 administration did
not affect the activation of encephalitogenic T cells as measured by
Ag-specific proliferation and the ability to adoptively transfer EAE.
These results demonstrate an important role for the CXC chemokine
CXCL10 in the recruitment and accumulation of inflammatory mononuclear
cells during the pathogenesis of EAE.
This article has been cited by other articles:
|
|
 |
|
  K. M. Omari, S. E. Lutz, L. Santambrogio, S. A. Lira, and C. S. Raine Neuroprotection and Remyelination after Autoimmune Demyelination in Mice that Inducibly Overexpress CXCL1 Am. J. Pathol., January 1, 2009; 174(1): 164 - 176. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.-N. E. Dogan, A. Elhofy, and W. J. Karpus Production of CCL2 by Central Nervous System Cells Regulates Development of Murine Experimental Autoimmune Encephalomyelitis through the Recruitment of TNF- and iNOS-Expressing Macrophages and Myeloid Dendritic Cells J. Immunol., June 1, 2008; 180(11): 7376 - 7384. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. Su, R. S. Grajewski, D. Luger, R. K. Agarwal, P. B. Silver, J. Tang, J. Tuo, C.-C. Chan, and R. R. Caspi Altered Chemokine Profile Associated with Exacerbated Autoimmune Pathology under Conditions of Genetic Interferon-{gamma} Deficiency Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4616 - 4625. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Muller, S. L. Carter, M. J. Hofer, P. Manders, D. R. Getts, M. T. Getts, A. Dreykluft, B. Lu, C. Gerard, N. J. C. King, et al. CXCR3 Signaling Reduces the Severity of Experimental Autoimmune Encephalomyelitis by Controlling the Parenchymal Distribution of Effector and Regulatory T Cells in the Central Nervous System J. Immunol., September 1, 2007; 179(5): 2774 - 2786. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Hansen, N. J. Bernard, C. Q. Nie, and L. Schofield NK Cells Stimulate Recruitment of CXCR3+ T Cells to the Brain during Plasmodium berghei-Mediated Cerebral Malaria J. Immunol., May 1, 2007; 178(9): 5779 - 5788. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M J Bugeja, D R Booth, B H Bennetts, R N. Heard, and G J Stewart An investigation of polymorphisms in the 4q13.3-21.1 CXC chemokine gene cluster for association with multiple sclerosis in Australians Multiple Sclerosis, November 1, 2006; 12(6): 710 - 722. [Abstract] [PDF]
|
|
|
|
 |
|
 Y.-N. Zhu, X.-G. Zhong, J.-Q. Feng, Y.-F. Yang, Y.-F. Fu, J. Ni, Q.-F. Liu, W. Tang, W.-M. Zhao, and J.-P. Zuo Periplocoside E Inhibits Experimental Allergic Encephalomyelitis by Suppressing Interleukin 12-Dependent CCR5 Expression and Interferon-{gamma}-Dependent CXCR3 Expression in T Lymphocytes J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1153 - 1162. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Nishimura, J. E. Dusak, J. Eguchi, X. Zhu, A. Gambotto, W. J. Storkus, and H. Okada Adoptive Transfer of Type 1 CTL Mediates Effective Anti-Central Nervous System Tumor Response: Critical Roles of IFN-Inducible Protein-10. Cancer Res., April 15, 2006; 66(8): 4478 - 4487. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Christensen, C. de Lemos, T. Moos, J. P. Christensen, and A. R. Thomsen CXCL10 Is the Key Ligand for CXCR3 on CD8+ Effector T Cells Involved in Immune Surveillance of the Lymphocytic Choriomeningitis Virus-Infected Central Nervous System J. Immunol., April 1, 2006; 176(7): 4235 - 4243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Liu, D. Huang, M. Matsui, T. T. He, T. Hu, J. DeMartino, B. Lu, C. Gerard, and R. M. Ransohoff Severe Disease, Unaltered Leukocyte Migration, and Reduced IFN-{gamma} Production in CXCR3-/- Mice with Experimental Autoimmune Encephalomyelitis J. Immunol., April 1, 2006; 176(7): 4399 - 4409. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yu, G. C. Sharp, and H. Braley-Mullen Thyrocytes Responding to IFN-{gamma} Are Essential for Development of Lymphocytic Spontaneous Autoimmune Thyroiditis and Inhibition of Thyrocyte Hyperplasia J. Immunol., January 15, 2006; 176(2): 1259 - 1265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Shigihara, A. Shimada, Y. Oikawa, H. Yoneyama, Y. Kanazawa, Y. Okubo, K. Matsushima, E. Yamato, J.-i. Miyazaki, A. Kasuga, et al. CXCL10 DNA Vaccination Prevents Spontaneous Diabetes through Enhanced {beta} Cell Proliferation in NOD Mice J. Immunol., December 15, 2005; 175(12): 8401 - 8408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Chen, Y. Wei, A. Alter, G. C. Sharp, and H. Braley-Mullen Chemokine expression during development of fibrosis versus resolution in a murine model of granulomatous experimental autoimmune thyroiditis J. Leukoc. Biol., September 1, 2005; 78(3): 716 - 724. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Omari, G. R. John, S. C. Sealfon, and C. S. Raine CXC chemokine receptors on human oligodendrocytes: implications for multiple sclerosis Brain, May 1, 2005; 128(5): 1003 - 1015. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Rappert, I. Bechmann, T. Pivneva, J. Mahlo, K. Biber, C. Nolte, A. D. Kovac, C. Gerard, H. W. G. M. Boddeke, R. Nitsch, et al. CXCR3-Dependent Microglial Recruitment Is Essential for Dendrite Loss after Brain Lesion J. Neurosci., September 29, 2004; 24(39): 8500 - 8509. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T L Sorensen, H Roed, and F Sellebjerg Optic neuritis: chemokine receptor CXCR3 and its ligands Br. J. Ophthalmol., September 1, 2004; 88(9): 1146 - 1148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Fukumoto, T. Shimaoka, H. Fujimura, S. Sakoda, M. Tanaka, T. Kita, and S. Yonehara Critical Roles of CXC Chemokine Ligand 16/Scavenger Receptor that Binds Phosphatidylserine and Oxidized Lipoprotein in the Pathogenesis of Both Acute and Adoptive Transfer Experimental Autoimmune Encephalomyelitis J. Immunol., August 1, 2004; 173(3): 1620 - 1627. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Christensen, A. Nansen, T. Moos, B. Lu, C. Gerard, J. P. Christensen, and A. R. Thomsen Efficient T-Cell Surveillance of the CNS Requires Expression of the CXC Chemokine Receptor 3 J. Neurosci., May 19, 2004; 24(20): 4849 - 4858. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Tsunoda, T. E Lane, J. Blackett, and R. S Fujinami Distinct roles for IP-10/C XC L10 in three animal models, Theiler's virus infection, EA E, and MHV infection, for multiple sclerosis: implication of differing roles for IP-10 Multiple Sclerosis, February 1, 2004; 10(1): 26 - 34. [Abstract] [PDF]
|
|
|
|
 |
|
 Y.-J. Day, M. A. Marshall, L. Huang, M. J. McDuffie, M. D. Okusa, and J. Linden Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction Am J Physiol Gastrointest Liver Physiol, February 1, 2004; 286(2): G285 - G293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Klein, L. Izikson, T. Means, H. D. Gibson, E. Lin, R. A. Sobel, H. L. Weiner, and A. D. Luster IFN-Inducible Protein 10/CXC Chemokine Ligand 10-Independent Induction of Experimental Autoimmune Encephalomyelitis J. Immunol., January 1, 2004; 172(1): 550 - 559. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Christen, D. B. McGavern, A. D. Luster, M. G. von Herrath, and M. B. A. Oldstone Among CXCR3 Chemokines, IFN-{gamma}-Inducible Protein of 10 kDa (CXC Chemokine Ligand (CXCL) 10) but Not Monokine Induced by IFN-{gamma} (CXCL9) Imprints a Pattern for the Subsequent Development of Autoimmune Disease J. Immunol., December 15, 2003; 171(12): 6838 - 6845. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Delgado Inhibition of Interferon (IFN) {gamma}-induced Jak-STAT1 Activation in Microglia by Vasoactive Intestinal Peptide: INHIBITORY EFFECT ON CD40, IFN-INDUCED PROTEIN-10, AND INDUCIBLE NITRIC-OXIDE SYNTHASE EXPRESSION J. Biol. Chem., July 18, 2003; 278(30): 27620 - 27629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. Kohler, A. C. Caon, D. O. Willenborg, I. Clark-Lewis, and S. R. McColl A Role for Macrophage Inflammatory Protein-3{alpha}/CC Chemokine Ligand 20 in Immune Priming During T Cell-Mediated Inflammation of the Central Nervous System J. Immunol., June 15, 2003; 170(12): 6298 - 6306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Denkinger, M. Denkinger, J. J. Kort, C. Metz, and T. G. Forsthuber In Vivo Blockade of Macrophage Migration Inhibitory Factor Ameliorates Acute Experimental Autoimmune Encephalomyelitis by Impairing the Homing of Encephalitogenic T Cells to the Central Nervous System J. Immunol., February 1, 2003; 170(3): 1274 - 1282. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yu, G. C. Sharp, and H. Braley-Mullen Dual Roles for IFN-{gamma}, But Not for IL-4, in Spontaneous Autoimmune Thyroiditis in NOD.H-2h4 Mice J. Immunol., October 1, 2002; 169(7): 3999 - 4007. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Salomon, N. Netzer, G. Wildbaum, S. Schif-Zuck, G. Maor, and N. Karin Targeting the Function of IFN-{gamma}-Inducible Protein 10 Suppresses Ongoing Adjuvant Arthritis J. Immunol., September 1, 2002; 169(5): 2685 - 2693. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Boztug, M. J. Carson, N. Pham-Mitchell, V. C. Asensio, J. DeMartino, and I. L. Campbell Leukocyte Infiltration, But Not Neurodegeneration, in the CNS of Transgenic Mice with Astrocyte Production of the CXC Chemokine Ligand 10 J. Immunol., August 1, 2002; 169(3): 1505 - 1515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. N. Kline, K. Kitagaki, T. R. Businga, and V. V. Jain Treatment of established asthma in a murine model using CpG oligodeoxynucleotides Am J Physiol Lung Cell Mol Physiol, July 1, 2002; 283(1): L170 - L179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Wildbaum, N. Netzer, and N. Karin Plasmid DNA Encoding IFN-{gamma}-Inducible Protein 10 Redirects Antigen-Specific T Cell Polarization and Suppresses Experimental Autoimmune Encephalomyelitis J. Immunol., June 1, 2002; 168(11): 5885 - 5892. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Dufour, M. Dziejman, M. T. Liu, J. H. Leung, T. E. Lane, and A. D. Luster IFN-{gamma}-Inducible Protein 10 (IP-10; CXCL10)-Deficient Mice Reveal a Role for IP-10 in Effector T Cell Generation and Trafficking J. Immunol., April 1, 2002; 168(7): 3195 - 3204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Zhang, L. Kaptanoglu, W. Haddad, D. Ivancic, Z. Alnadjim, S. Hurst, D. Tishler, A. D. Luster, T. A. Barrett, and J. Fryer Donor T Cell Activation Initiates Small Bowel Allograft Rejection Through an IFN-{gamma}-Inducible Protein-10-Dependent Mechanism J. Immunol., April 1, 2002; 168(7): 3205 - 3212. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
